Compare

Omada Health, Inc. vs GeneDx Holdings Corp. vs Pennant Group, Inc. vs InnovAge Holding Corp.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearOmada Health, Inc.
OMDA
GeneDx Holdings Corp.
WGS
Pennant Group, Inc.
PNTG
InnovAge Holding Corp.
INNV
Year ended2025-12-312025-12-312025-12-312026-06-30
Revenue$260.21M$427.54M$947.71M$989.71M
Revenue growth (YoY)+53.2%+40.0%+36.3%+15.9%
Gross margin65.7%69.7%n/a23.0%
Operating margin-4.6%-3.1%5.5%0.3%
Net margin-4.9%-4.9%3.1%-0.3%
Net income-$12.78M-$21.02M$29.58M-$2.54M
EPS (Diluted)-$0.35-$0.73$0.84-$0.02
Operating cash flow$18.25M$33.28M$48.29M$64.71M
Free cash flow$16.93M$14.26M$36.26M$50.41M
Cash & equivalents$222.04M$105.00Mn/a$97.89M
Total assets$305.41M$523.71M$968.18M$557.39M
Total liabilities$75.73M$215.53M$593.93M$288.62M
Shareholders' equity$229.68M$308.18M$374.25M$235.60M
Return on year-end equity-5.6%-6.8%7.9%-1.1%
Shares outstanding58.43M29.25M34.63M136.02M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearOmada Health, Inc.GeneDx Holdings Corp.Pennant Group, Inc.InnovAge Holding Corp.
Latest$260.21M
Ended 2025-12-31
$427.54M
Ended 2025-12-31
$947.71M
Ended 2025-12-31
$989.71M
Ended 2026-06-30
1 year earlier$169.80M
Ended 2024-12-31
$305.45M
Ended 2024-12-31
$695.24M
Ended 2024-12-31
$853.70M
Ended 2025-06-30
2 years earlier$122.78M
Ended 2023-12-31
$202.57M
Ended 2023-12-31
$544.89M
Ended 2023-12-31
$763.86M
Ended 2024-06-30
3 years earliern/a$234.69M
Ended 2022-12-31
$473.24M
Ended 2022-12-31
$688.09M
Ended 2023-06-30
4 years earliern/a$212.19M
Ended 2021-12-31
$439.69M
Ended 2021-12-31
$698.64M
Ended 2022-06-30